Amwill Healthcare, one of India's fastest-growing dermatology companies, is set to launch its IPO on February 5, 2025. The company specializes in dermatology, trichology, and cosmetology, using high-tech advanced active ingredients combined with natural elements and allopathic actives. This ensures effective and visible results, making Amwill Healthcare a promising player in the cosmetic and pharmaceutical industry.

IPO Details and Issue Structure

The Amwill Healthcare IPO is a Book Built Issue worth ₹ 59.97 Crores. The fresh issue consists of 44.03 lakh shares totaling ₹ 48.87 Crores, while the Offer for Sale (OFS) includes 10 lakh shares worth ₹ 11.1 Crores. The IPO will be listed on BSE SME, with a tentative listing date of February 12, 2025.

The price band for the IPO is set at ₹ 105-₹ 111 per share, and the market capitalization at the upper price band will be ₹ 222.04 Crores. Investors looking to participate in the IPO must purchase shares in lots of 1,200 shares, with a minimum investment of ₹ 1,33,200 for retail investors and ₹ 2,66,400 for HNIs (2 lots).

Financial Performance and Key Ratios

Amwill Healthcare has demonstrated steady financial growth over the years. Below are some key financial metrics:

• Revenue from operations:

  • FY22: ₹ 27.61 Crores

  • FY23: ₹ 30.28 Crores

  • FY24: ₹ 44.28 Crores

  • H1 FY25: ₹ 23.24 Crores

• EBITDA Growth:

  • FY22: ₹ 3.66 Crores

  • FY23: ₹ 4.41 Crores

  • FY24: ₹ 17.00 Crores

  • H1 FY25: ₹ 8.93 Crores

• Profit After Tax (PAT):

  • FY22: ₹ 2.57 Crores

  • FY23: ₹ 3.11 Crores

  • FY24: ₹ 12.53 Crores

  • H1 FY25: ₹ 6.51 Crores

The company reports a pre-issue EPS of ₹ 8.04 and post-issue EPS of ₹ 6.27, with a post-issue P/E ratio of 17.71x compared to the industry P/E ratio of 36x.

IPO Subscription and Allotment Process

The Amwill Healthcare IPO subscription period is from February 5 to February 7, 2025. The allotment is expected to be finalized on February 10, 2025, and investors can check their allotment status by following these steps:

1. Visit the registrar's website (Bigshare Services Private Limited).

2. Select "Amwill Healthcare IPO" from the dropdown list.

3. Enter your application number, PAN, or DP Client ID.

4. Submit the details to check allotment status.

GMP and Expected Listing Price

As per market reports, the Grey Market Premium (GMP) for Amwill Healthcare IPO is currently ₹ 0, indicating no listing gains expected. Since GMP is highly speculative, investors should focus on fundamentals and long-term growth potential rather than relying on GMP trends.

Objective of the IPO

The net proceeds from the IPO will be utilized as follows:

1. ₹ 25 Crores for working capital requirements.

2. ₹ 5 Crores for marketing and brand-building activities.

3. The remaining funds will be allocated for general corporate purposes.

Lead Managers and Market Maker

The IPO is managed by Unistone Capital Private Limited as the book running lead manager, while Bigshare Services Private Limited is the registrar. Globalworth Securities Limited is the market maker.

Should You Invest in Amwill Healthcare IPO?

While Amwill Healthcare has shown consistent financial growth, the IPO appears to be fully priced with a P/E ratio of 17.71x. The company’s return on capital employed (ROCE) of 94.16% and return on equity (ROE) of 73.06% indicate strong profitability. However, due to a lack of Grey Market Premium (GMP), short-term listing gains may be limited. Investors should consider their risk appetite and long-term goals before applying.

The Upcoming IPOs in this week and coming weeks are Ken Enterprises, Amwill Healthcare, Readymix Construction, Solarium Green, Eleganz Interiors.

The Current active IPO is Chamunda Electricals.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.